Measles - 25 Studies Found
Not yet recruiting |
: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella :
: 2017-05-09 :
|
Completed |
: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age : Measles; Mumps; Rubella : 2014-07-03 :
|
Completed |
: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella :
: 2014-07-16 : Biological: Double viral (MR) vaccine Measles and Rubella vaccine, as single arm |
Completed |
: Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer :
: 2009-01-22 : Biological: attenuated measles vaccine 4-week apart, two vaccines starting 4 weeks after last chemothera |